Mariner’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-4,811
Closed -$1.57M 3320
2024
Q1
$1.57M Buy
4,811
+101
+2% +$24.8K ﹤0.01% 1236
2023
Q4
$898K Buy
4,710
+1,276
+37% +$241K ﹤0.01% 1506
2023
Q3
$684K Sell
3,434
-478
-12% -$113K ﹤0.01% 1562
2023
Q2
$1.12M Buy
3,912
+113
+3% +$31.4K ﹤0.01% 1238
2023
Q1
$823K Buy
3,799
+47
+1% +$9.16K ﹤0.01% 1381
2022
Q4
$771K Buy
3,752
+185
+5% +$46.8K ﹤0.01% 1373
2022
Q3
$992K Buy
+3,567
New +$907K ﹤0.01% 1049

Other funds holding SWAV

Mariner's SWAV Position: Q2 2024 in Review

Mariner sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 4,811 shares — an estimated $1.57M sold.

Mariner first reported a position in SWAV in Q3 2022 and held it in 7 quarters. The position peaked at $1.57M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Mariner reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Mariner sold 4,811 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $1.57M.
  • Mariner first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
  • Mariner's Shockwave Medical, Inc. Common Stock position peaked at $1.57M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Mariner's 13F filing for Q2 2024, filed 13 Aug 2024.